Group Director, Clinical Pharmacology and Pharmacometrics,
Johnson and Johnson Innovative Medicine
Medford, Massachusetts
Dr. Aman Singh is currently working as a Group Director of Clinical Pharmacology and Pharmacometrics at Johnson & Johnson, where he is responsible as a group leader applying QSP and MIDD approaches towards the Oncology, Neuroscience and Immunology therapeutic areas.
Before this role, he used to work in Takeda as a Director of Clinical Pharmacology and Scientist/Sr. Scientist in Translational PK-PD group at Janssen Biotherapeutics focussing on oncology projects using ADCs, bispecifics and CAR-Ts as therapeutic modality.
He received his BS in Pharmacy, MS and PhD in Pharmaceutical Sciences in State University of New York at Buffalo.
Disclosure information not submitted.
Quantitative Pharmacology of anti-CD19 Cell Therapies in Autoimmune conditions
Wednesday, November 12, 2025
10:30 AM - 11:00 AM CT